TARA CIK: 1359931

Protara Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.5
FY22:
−26.5
FY23:
−37.6
FY24:
−35.8
FY25:
−56.4
Change from FY21 to FY25
millions USD
FY21:
−98.2
FY22:
15.0
FY23:
53.1
FY24:
19.2
FY25:
−139
Change from FY21 to FY25
millions USD
FY21:
−0.23
FY22:
−0.09
FY23:
−0.09
FY24:
140
FY25:
82.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.1
FY22:
−26.6
FY23:
−37.6
FY24:
−35.9
FY25:
−56.5

All amounts in millions USD Data source:SEC EDGAR